Immunome Inc. (IMNM) on GreekSoup https://greeksoup.ai/stocks/us/imnm/ Every dated entry in the public record on Immunome Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Immunome Inc.: short interest 17,281,614 shares at the 15 October 2026 settlement, 12.16 days to coverhttps://greeksoup.ai/stocks/us/imnm/short-interest/us:IMNM:short-interest:2026-10-15:5fbfad4461Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Immunome Inc. filed 8-K: material agreement, unregistered sale of equityhttps://greeksoup.ai/stocks/us/imnm/filings/us:IMNM:filing:2026-10-05:8fe122231fMon, 05 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Immunome Inc.: short interest 16,757,287 shares at the 30 September 2026 settlement, 9.91 days to coverhttps://greeksoup.ai/stocks/us/imnm/short-interest/us:IMNM:short-interest:2026-09-30:c57c613844Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Immunome Inc.: Higgins Jack (Chief Scientific Officer) sold 13,200 shares (under a trading plan set in advance) at $25.32 on 11 September 2026, $334,224https://greeksoup.ai/stocks/us/imnm/insiders/us:IMNM:insider:2026-09-15:234efc8865Tue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Immunome Inc.: short interest 16,244,557 shares at the 15 September 2026 settlement, 20.63 days to coverhttps://greeksoup.ai/stocks/us/imnm/short-interest/us:IMNM:short-interest:2026-09-15:e40f7b500dTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Immunome Inc.: Form 144, Higgins Jack plans to sell 13,200 shares worth $334,224 around 11 September 2026https://greeksoup.ai/stocks/us/imnm/planned-sales/us:IMNM:planned-sale:2026-09-11:6e22f362c3Fri, 11 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Immunome Inc.: short interest 15,634,596 shares at the 31 August 2026 settlement, 12.64 days to coverhttps://greeksoup.ai/stocks/us/imnm/short-interest/us:IMNM:short-interest:2026-08-31:3aaa2a8857Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Immunome Inc.: Schedule 13G/A filed by T. Rowe Price Investment Management, Inc., 17.4% of the classhttps://greeksoup.ai/stocks/us/imnm/holders/us:IMNM:schedule-13:2026-08-14:8ab87bcb26Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Immunome Inc.: Schedule 13G/A filed by Sirenia Capital Management LP, 4.3% of the classhttps://greeksoup.ai/stocks/us/imnm/holders/us:IMNM:schedule-13:2026-08-14:ebbf6824dcFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Immunome Inc.: short interest 17,392,529 shares at the 14 August 2026 settlement, 14.93 days to coverhttps://greeksoup.ai/stocks/us/imnm/short-interest/us:IMNM:short-interest:2026-08-14:997857a13aFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Immunome Inc.: Form 144, Barchas Isaac plans to sell 11,048 shares worth $301,058 around 12 August 2026https://greeksoup.ai/stocks/us/imnm/planned-sales/us:IMNM:planned-sale:2026-08-12:7adbd5d93bWed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Immunome Inc.: Barchas Isaac (Director) sold 11,048 shares (under a trading plan set in advance) at $27.25 on 12 August 2026, $301,058https://greeksoup.ai/stocks/us/imnm/insiders/us:IMNM:insider:2026-08-12:a46795d139Wed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Immunome Inc.: Barchas Isaac (Director), see footnote, sold 62,291 shares (under a trading plan set in advance) at $26.23 on 11 August 2026, $1.6 millionhttps://greeksoup.ai/stocks/us/imnm/insiders/us:IMNM:insider:2026-08-12:54d0724917Wed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Immunome Inc.: Barchas Isaac (Director), see footnote, sold 10,125 shares (under a trading plan set in advance) at $26.07 on 10 August 2026, $263,959https://greeksoup.ai/stocks/us/imnm/insiders/us:IMNM:insider:2026-08-12:ad6462d758Wed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Immunome Inc. Q2 FY2026 results: revenue $0, net income -$73 millionhttps://greeksoup.ai/stocks/us/imnm/results/fy2026-q2/us:IMNM:result:2026-08-11:0a0fade952Tue, 11 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Immunome Inc. filed S-8: s-8https://greeksoup.ai/stocks/us/imnm/filings/us:IMNM:filing:2026-08-11:895d181d0eTue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Immunome Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/imnm/filings/us:IMNM:filing:2026-08-11:0ed211cc8eTue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Immunome Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/imnm/filings/us:IMNM:filing:2026-08-11:806f2e4accTue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Immunome Inc.: Barchas Isaac (Director), see footnote, sold 15,248 shares (under a trading plan set in advance) at $26.06 on 7 August 2026, $397,363https://greeksoup.ai/stocks/us/imnm/insiders/us:IMNM:insider:2026-08-10:ccaddf30efMon, 10 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Immunome Inc.: Barchas Isaac (Director), see footnote, sold 20,840 shares (under a trading plan set in advance) at $26.06 on 6 August 2026, $543,090https://greeksoup.ai/stocks/us/imnm/insiders/us:IMNM:insider:2026-08-10:f3019aa9eaMon, 10 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Immunome Inc.: Form 144, ABHMC II, LLC plans to sell 108,504 shares worth $2.8 million around 6 August 2026https://greeksoup.ai/stocks/us/imnm/planned-sales/us:IMNM:planned-sale:2026-08-06:59dfd886feThu, 06 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Immunome Inc.: Horn Kinney (CHIEF BUSINESS OFFICER) sold 90,616 shares (under a trading plan set in advance) at $25.09 on 4 August 2026, $2.3 millionhttps://greeksoup.ai/stocks/us/imnm/insiders/us:IMNM:insider:2026-08-06:31e098b4beThu, 06 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Immunome Inc.: Form 144, Horn Kinney plans to sell 90,616 shares worth $2.3 million around 4 August 2026https://greeksoup.ai/stocks/us/imnm/planned-sales/us:IMNM:planned-sale:2026-08-04:14166bfa89Tue, 04 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Immunome Inc.: short interest 17,981,724 shares at the 31 July 2026 settlement, 22.98 days to coverhttps://greeksoup.ai/stocks/us/imnm/short-interest/us:IMNM:short-interest:2026-07-31:a42be69864Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>